Prolonged QT Interval in SARS-CoV-2 Infection: Prevalence and Prognosis.
Prolonged QT Interval in SARS-CoV-2 Infection: Prevalence and Prognosis.
复制标题
DOI:
10.3390/jcm9092712
复制
发表时间:
2020-08-21
影响因子:
3.9
通讯作者:
Vaquerizo B
中科院分区:
文献类型:
--
作者:
Farré N;Mojón D;Llagostera M;Belarte-Tornero LC;Calvo-Fernández A;Vallés E;Negrete A;García-Guimaraes M;Bartolomé Y;Fernández C;García-Duran AB;Marrugat J;Vaquerizo B
Background: The prognostic value of a prolonged QT interval in SARS-Cov2 infection is not well known. Objective: To determine whether the presence of a prolonged QT on admission is an independent factor for mortality in SARS-Cov2 hospitalized patients. Methods: Single-center cohort of 623 consecutive patients with positive polymerase-chain-reaction test (PCR) to SARS Cov2, recruited from 27 February to 7 April 2020. An electrocardiogram was taken on these patients within the first 48 h after diagnosis and before the administration of any medication with a known effect on QT interval. A prolonged QT interval was defined as a corrected QT (QTc) interval >480 milliseconds. Patients were followed up with until 10 May 2020. Results: Sixty-one patients (9.8%) had prolonged QTc and only 3.2% had a baseline QTc > 500 milliseconds. Patients with prolonged QTc were older, had more comorbidities, and higher levels of immune-inflammatory markers. There were no episodes of ventricular tachycardia or ventricular fibrillation during hospitalization. All-cause death was higher in patients with prolonged QTc (41.0% vs. 8.7%, p < 0.001, multivariable HR 2.68 (1.58–4.55), p < 0.001). Conclusions: Almost 10% of patients with COVID-19 infection have a prolonged QTc interval on admission. A prolonged QTc was independently associated with a higher mortality even after adjustment for age, comorbidities, and treatment with hydroxychloroquine and azithromycin. An electrocardiogram should be included on admission to identify high-risk SARS-CoV-2 patients.
登录
查看更多内容
影响因子:
1.3
作者:
Alexander LK;Keene BW;Yount BL;Geratz JD;Small JD;Baric RS
通讯作者:
Baric RS
影响因子:
1.9
作者:
Furlan-Daniel, Rosemary Aparecida;Silveira Santos, Luis Felipe;Bestetti, Reinaldo Bulgarelli
通讯作者:
Bestetti, Reinaldo Bulgarelli
DOI:
10.1164/rccm.202005-1583oc
发表时间:
2020-09-15
影响因子:
24.7
作者:
McElvaney, Oliver J.;McEvoy, Natalie L.;McElvaney, Noel G.
通讯作者:
McElvaney, Noel G.
DOI:
10.1111/j.1540-8167.2006.00408.x
发表时间:
2006-03-01
影响因子:
2.7
作者:
Goldenberg, I;Moss, AJ;Zareba, W
通讯作者:
Zareba, W
影响因子:
6.4
作者:
EDWARDS, S;SMALL, JD;BARIC, RS
通讯作者:
BARIC, RS